You are viewing the site in preview mode
Skip to main content
|
Parameter
|
Per protocol group (N= 82)
|
ITT group (N= 97)a
|
Missed patientsb(N= 80)
|
|---|
|
Age (median, IQR)
|
47 (40 to 55)
|
48 (40 to 55)
|
49 (41 to 56)
|
|
Gender (N, %)
|
43, 52%
|
53, 55%
|
36, 46%
|
|
Arrival by ambulance (N, %)
|
59, 72%
|
70, 72%
|
62, 79%
|
|
Killip class 1 (N, %)
|
81, 99%
|
95, 98%
|
76, 96%
|
|
History of hypertension (N, %)
|
17, 21%
|
20, 21%
|
16, 20%
|
|
History of diabetes (N, %)
|
5, 6%
|
5, 5%
|
2, 3%
|
|
History of elevated cholesterol/cholesterol treatment (N, %)
|
16, 20%
|
18, 19%
|
21, 27%
|
|
Smoker (N, %)
|
27, 33%
|
32, 33%
|
16, 20%
|
|
Family history CAD (N, %)
|
22, 27%
|
28, 29%
|
22, 28%
|
|
Hospital admission (N, %)
|
3, 4%
|
5, 5%
|
6, 8%
|
|
GRACE risk score (median, IQR)
|
70 (60 to 88)
|
70 (59 to 88)
|
77 (60 to 89)
|
|
GRACE freedom from events score (median, IQR)
|
323 (312 to 333)
|
323 (311 to 333)
|
325 (312 to 336)
|
|
MACE at 7 days (N, %, 95% CI)
|
0, 0%, 0% to 4.5%
|
0, 0%, 0% to 3.8%
|
0, 0%, 0% to 4.6%
|
|
MACE at 30 days (N, %, 95% CI)
|
0, 0%, 0% to 4.5%
|
0, 0%, 0% to 3.8%
|
0, 0%, 0% to 4.6%
|
|
MACE or revascularization at 30 days (N, %, 95% CI)
|
0, 0%, 0% to 4.5%
|
0, 0%, 0% to 3.8%
|
1, 1.3%, 0.2% to 6.8%
|
- ITT, intention to treat; IQR, interquartile range; CAD, coronary artery disease; GRACE, Global Risk Acute Coronary Events Registry; MACE, major adverse cardiac events. aIncludes per protocol group; bstandard biomarker interval only, no 2-h specimen.
